In June, the US Food and Drug Administration (FDA) launched an accelerated review of a promising new drug for advanced prostate cancer. Called relugolix, it suppresses testosterone and other hormones that speed the cancer’s growth. If approved, this new type of hormonal therapy is expected to set a new standard of care for the disease.… Read More »
FRIDAY, April 10, 2020 — A type of talk therapy by phone may help treat depression in people with Parkinson’s disease, researchers say. Depression is common in Parkinson’s disease patients. It’s associated with faster physical and mental decline, but is often overlooked and undertreated. While cognitive behavioral therapy (CBT) has shown promise in easing depression… Read More »
Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »
In a few short weeks, the novel coronavirus pandemic has upturned countries around the world, presenting new and complex workplace challenges. That shift is also true for drugmakers working to combat COVID-19. For New York-based Regeneron––at the forefront of the COVID-19 hunt––those challenges are unprecedented and extraordinary, but it’s still mostly business as usual. After… Read More »
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients. X-linked retinitis pigmentosa, caused by mutations in RPGR gene, is the most common cause of blindness in young people. The inherited mutations lead to degeneration of light… Read More »
Atrial fibrillation, once a rarity, is now quite common with approximately 6,000 cases being seen a year in the UK. It can be successfully treated with drugs, however, ablation therapy, is now seen as a procedure for patients whose atrial fibrillation is causing palpitations or breathlessness, and who haven’t responded to drugs or don’t want… Read More »